NFL BIOSCIENCES SA (ALNFL.PA) Stock Price, Forecast & Analysis

EPA:ALNFL • FR0014003XT0

1.1 EUR
-0.06 (-5.17%)
Last: Mar 2, 2026, 07:00 PM

ALNFL.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap13.94M
Revenue(TTM)N/A
Net Income(TTM)-1.83M
Shares12.67M
Float10.42M
52 Week High1.86
52 Week Low0.85
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.36
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2021-07-05
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
ALNFL.PA short term performance overview.The bars show the price performance of ALNFL.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

ALNFL.PA long term performance overview.The bars show the price performance of ALNFL.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ALNFL.PA is 1.1 EUR. In the past month the price decreased by -14.73%. In the past year, price decreased by -33.57%.

NFL BIOSCIENCES SA / ALNFL Daily stock chart

ALNFL.PA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ALNFL.PA. When comparing the yearly performance of all stocks, ALNFL.PA is a bad performer in the overall market: 88.83% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
ALNFL.PA Full Technical Analysis Report

ALNFL.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ALNFL.PA. The financial health of ALNFL.PA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ALNFL.PA Full Fundamental Analysis Report

ALNFL.PA Financial Highlights

Over the last trailing twelve months ALNFL.PA reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 54.35% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -50.64%
ROE -84.25%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-423.53%
Sales Q2Q%N/A
EPS 1Y (TTM)54.35%
Revenue 1Y (TTM)N/A
ALNFL.PA financials

ALNFL.PA Forecast & Estimates

11 analysts have analysed ALNFL.PA and the average price target is 2.99 EUR. This implies a price increase of 172% is expected in the next year compared to the current price of 1.1.


Analysts
Analysts81.82
Price Target2.99 (171.82%)
EPS Next Y-93.75%
Revenue Next YearN/A
ALNFL.PA Analyst EstimatesALNFL.PA Analyst Ratings

ALNFL.PA Ownership

Ownership
Inst Owners0.08%
Ins Owners17.79%
Short Float %N/A
Short RatioN/A
ALNFL.PA Ownership

About ALNFL.PA

Company Profile

ALNFL logo image NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. The company is headquartered in Castelnau-Le-Lez, Occitanie and currently employs 4 full-time employees. The company went IPO on 2021-07-05. The firm's products help cure addictions through an approach based on botanical pharmaceutical agents. The company develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The firm applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.

Company Info

NFL BIOSCIENCES SA

199 rue Helene Boucher

Castelnau-le-Lez OCCITANIE FR

Employees: 5

ALNFL Company Website

Phone: 33411937667

NFL BIOSCIENCES SA / ALNFL.PA FAQ

Can you describe the business of NFL BIOSCIENCES SA?

NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. The company is headquartered in Castelnau-Le-Lez, Occitanie and currently employs 4 full-time employees. The company went IPO on 2021-07-05. The firm's products help cure addictions through an approach based on botanical pharmaceutical agents. The company develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The firm applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.


What is the stock price of NFL BIOSCIENCES SA today?

The current stock price of ALNFL.PA is 1.1 EUR. The price decreased by -5.17% in the last trading session.


Does ALNFL stock pay dividends?

ALNFL.PA does not pay a dividend.


What is the ChartMill rating of NFL BIOSCIENCES SA stock?

ALNFL.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the number of employees for NFL BIOSCIENCES SA?

NFL BIOSCIENCES SA (ALNFL.PA) currently has 5 employees.


Can you provide the market cap for NFL BIOSCIENCES SA?

NFL BIOSCIENCES SA (ALNFL.PA) has a market capitalization of 13.94M EUR. This makes ALNFL.PA a Nano Cap stock.


Can you provide the ownership details for ALNFL stock?

You can find the ownership structure of NFL BIOSCIENCES SA (ALNFL.PA) on the Ownership tab.